Nomic Bio

Protein profiling is too low-throughput and expensive for large-scale drug discovery and requires fragmented legacy immunoassay tools.

Nomic’s nELISA is a next-generation high-throughput immunoassay platform that profiles hundreds of proteins at much higher throughput and lower cost than existing methods.

High-throughput screening and drug discovery teams at pharmaceutical companies and biotech labs use it.